NCT05512260 2026-02-11
BESTa
Karolinska Institutet
Phase NA Withdrawn
Clinical Trials
12 trialsNCT07226102 2026-02-04
Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer
City of Hope Medical Center
Phase NA Withdrawn
NCT04826029 2021-12-10
QUALOV
Assistance Publique - Hôpitaux de Paris
Phase NA Withdrawn
NCT02530606 2018-11-28
Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer
Stanford University
Phase NA Withdrawn
NCT02878980 2018-06-15
An Exercise Intervention Trial to Reduce Symptoms & Improve Clinical Outcomes of Platinum-Based Treatment in Ovarian Cancer Patients
City of Hope Medical Center
Phase NA Withdrawn
NCT00551265 2017-07-14
Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy
GOG Foundation
Phase NA Withdrawn
NCT02704650 2017-04-27
Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal Fluids
Shaare Zedek Medical Center
Phase NA Withdrawn
NCT02667925 2016-10-11
ISOTOVE
Centre Jean Perrin
Phase NA Withdrawn
NCT01228942 2014-06-06
A Prospective Trial of COXEN Chemotherapy Prediction
University of Virginia
Phase NA Withdrawn
NCT00084370 2013-08-22
Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
University of Alabama at Birmingham
Phase NA Withdrawn
NCT00477867 2013-06-10
Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172
GOG Foundation
Phase NA Withdrawn
NCT00173407 2012-12-27
PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion
National Taiwan University Hospital
Phase NA Withdrawn